{"id":228242,"date":"2026-01-02T22:13:52","date_gmt":"2026-01-03T04:13:52","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/01\/cardiovascular-risk-score-identifies-risk-for-ocular-disease"},"modified":"2026-01-02T22:13:52","modified_gmt":"2026-01-03T04:13:52","slug":"cardiovascular-risk-score-identifies-risk-for-ocular-disease","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/01\/cardiovascular-risk-score-identifies-risk-for-ocular-disease","title":{"rendered":"Cardiovascular risk score identifies risk for ocular disease"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/cardiovascular-risk-score-identifies-risk-for-ocular-disease.jpg\"><\/a><\/p>\n<p>The Pooled Cohort Equations (PCE) cardiovascular risk score stratifies risk for multiple ocular diseases, according to a study <a href=\"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642025008024\" target=\"_blank\">published<\/a> online in Ophthalmology.<\/p>\n<p>Deyu Sun, Ph.D., from the David Geffen School of Medicine at the University of California Los Angeles, and colleagues conducted a historical prospective cohort study using electronic health record data from the \u201cAll of Us\u201d Research Program to examine whether the PCE cardiovascular risk score is associated with future age-related macular degeneration (AMD), glaucoma, diabetic retinopathy (DR), retinal vein occlusion (RVO), and hypertensive retinopathy (HTR).<\/p>\n<p>A total of 35,909 adults aged 40 to 79 years with complete variables for PCE calculation within a six-month period were included in the study. Individual-level <a href=\"https:\/\/medicalxpress.com\/news\/2023-10-real-world-reliability-tool-year-heart.html?utm_source=embeddings&utm_medium=related&utm_campaign=internal\" rel=\"related\">PCE score<\/a> was classified into four risk categories.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Pooled Cohort Equations (PCE) cardiovascular risk score stratifies risk for multiple ocular diseases, according to a study published online in Ophthalmology. Deyu Sun, Ph.D., from the David Geffen School of Medicine at the University of California Los Angeles, and colleagues conducted a historical prospective cohort study using electronic health record data from the \u201cAll [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,41,269],"tags":[],"class_list":["post-228242","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-information-science","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=228242"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228242\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=228242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=228242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=228242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}